UnitedHealth Group UNH Receives Price Target Upgrade as Managed Care Sector Shows Margin Recovery Potential The Feds Path to Rate Cuts Narrows as CostofLiving Pressures Intensify SP 500 and Nasdaq Hit Record Closings on AI Optimism Micron Reaches 1 Trillion Milestone Investment Manager Trims Stock Position Following 80 Surge Since April Oil Prices Decline as Market Hopes for USIran Peace Deal Grow Japans Nikkei 225 Surpasses 64000 for First Time as Oil Prices Slide on Hormuz Reopening Hopes Protara Therapeutics TARA Q1 2026 Earnings Narrower Loss Beats Street Estimates on Cost Management Ingredion INGR Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Strength Xtant Medical Holdings Inc XTNT Q1 2026 Earnings EPS Misses Estimates Amidst Narrow Loss RideNow Group Inc RDNW Q1 2026 Earnings SmallerThanExpected Loss Provides Modest Relief DUOL Q1 2026 Earnings EPS Beats Estimates by 164 Stock Edges Higher TSS Inc Q1 2026 Earnings Strong EPS Surprise of 170 Outpaces Estimates Cellebrite DI Ltd CLBT Slips 197 as Shares Test Key Support at 1227 Magic Empire Global Limited MEGL Edges Up 088 Amid Consolidation Near Resistance Targa Resources Holds Near Midpoint as Energy Sector Navigates Mixed Signals Oportun Financial OPRT Hovers Near Support as Modest Decline Persists Knife Riv Holding Co KNF Surges 34 on Strong Volume Approaches Key Resistance Japans Megabanks Report Record Profits Amid Rising Credit and Geopolitical Risks GXO Logistics Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain Thornburg Income Builder Opportunities Trust TBLD Gains 128 Tests Key Resistance Levels Repligen Corporation RGEN Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Not Disclosed SOBO Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Outlook Therapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Surges 29 DXCM Q1 2026 Earnings EPS Surges Past Estimates by 17 Amidst Market Skepticism SF Q1 2026 Earnings EPS Slightly Exceeds Estimates Shares Dip TECH Q1 2026 Earnings EPS Misses Estimates but Stock Rises 177 Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status